Synthesized corneas may restore sight to cloudy eyes

Bioengineers say substitutes may be available in a few years

September 29, 2006|By Linda Marsa | Linda Marsa,LOS ANGELES TIMES

The cornea of the eye seems so simple a structure - yet it's so important and so tricky to re-create in a lab. It is the eye's protective window, keeping out dirt, debris and germs. It's a lens that helps focus light so that we can see.

But when a cornea becomes cloudy or scarred from disease, injury or infection, the path of light into the eye can be distorted or blocked, resulting in blindness.

Transplanting human corneas from cadavers can restore someone's vision. But because of a tissue shortage, only 100,000 corneal transplants are performed worldwide annually - serving just 1 percent of the 10 million people who are stricken with corneal blindness. This shortfall, as well as problems with such transplants even when available, has spurred the quest for an artificial version of one of nature's masterpieces.

"The holy grail is a synthetic implant that is as strong, clear and flexible as a natural cornea, that would fully integrate into surrounding tissue and last forever," says Jean-Marie Parel, head of the Ophthalmic Biophysics Laboratory at the Bascom Palmer Eye Institute in Miami. "That way, we could implant this at any time, day or night, without having to hope that someone died."

Bioengineers are making significant progress. They predict that within a few years we could have cornea substitutes that slip over the surface of the eye as easily as contact lenses and mesh neatly with surrounding tissue to form a protective barrier against the outside elements.

Such devices would be of great use even in the United States, where the shortage of corneal tissue isn't critical but where other problems exist. More than 46,000 Americans undergo cornea transplants each year. They must use steroidal eyedrops (which have side effects) to prevent tissue rejection and endure a lengthy recovery period of up to six months; sometimes they are left with astigmatism, an uneven contour of the cornea that causes blurriness. Up to 10 percent of corneal transplants fail.

The new devices are also expected to improve on two artificial corneas that are already approved by the Food and Drug Administration: one called the Dohlman, developed at Harvard University; and a newer one, the AlphaCor, created by Australian scientists.

In both cases, patients can develop inflammation and infections, and sometimes the devices pop out. In the case of the Dohlman implant, human donor tissue is required. For these reasons, they are used only as a last resort for people who repeatedly have rejected natural corneas or who can't receive donated tissue because of severe eye diseases.

The cornea is a highly organized group of cells and proteins arranged in five basic layers. The outermost layer - the epithelium - blocks foreign material and bacteria, and absorbs oxygen and nutrients from tears. It is filled with thousands of tiny nerve endings that make the cornea sensitive to pain.

Other structures include the Bowman's layer and the stroma, both composed mainly of water and collagen, which give the cornea its strength and elasticity and help preserve its transparency. Below the stroma is Descemet's membrane, a thin sheet of tissue that protects against infection and injury. Finally, there's the innermost endothelium, which prevents excess fluids from collecting in the cornea.

Researchers at the University of Ottawa Eye Institute in Canada are working on one artificial device that has many of the properties of the real thing. It is made from a strong, synthetic collagen gel (derived from pigs), with a high water content, that forms a network of ultra-thin, near-invisible fibers. It is engineered in a way that enables it to knit seamlessly with the surrounding tissue during the healing process.

When the device was implanted into pigs, dogs and rabbits, cells from the animal grew over the device to form a new epithelial surface. Nerve cells grew into it too. Both are huge steps forward, says Parel. The epithelial cells form a protective barrier. The reattached nerves tell the brain when to blink and generate tears so that the cornea won't dry out.

This repopulation with human cells can occur because the device is made of substances that are engineered to structurally resemble natural tissue - and thus, the body is fooled into believing it is the real thing, says May Griffith, a cell biologist with the University of Ottawa research team. The scientists hope to begin human tests within the next year.

Scientists at Stanford University in California have taken a slightly different approach. Their artificial cornea is made of two interwoven networks of water-based synthetic gels designed to create a structure that is strong and flexible. Collagen is placed at the outer edges to help mesh the natural and artificial tissues and promote the growth of a clear layer of epithelial cells over the implant.

Baltimore Sun Articles
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.